• Home
• About us
  • U.S. LEADERSHIP
    • Adam Gluck
    • Carole Huntsman
    • Chan Lee
    • Elaine O'Hara
    • Gustavo Pesquin
  • Awards and Recognitions
  • Corporate Compliance
    • Compliance Program for Sanofi Pasteur
    • California Compliance Law
    • Committed to Transparency
  • Vaccines
  • Our Stories
    • Inside Sanofi
    • 2020 TORCH Awards
    • 2021 TORCH Awards
    • Adapting to Stay Ahead of Preventable Infectious Threats
    • COVID-19: One Year Later
    • Flu season is here: Help protect yourself and your family against a yearly threat
    • Listening to Learn: Patient Perspective on Autosomal Dominant Polycystic Kidney Disease
    • Our Response to COVID-19
    • How Registries Accelerate Rare Disease Research
    • Without Hesitation: Joel Navigates the Long Road of aTTP
    • Reflecting on Disease Prevention on World Meningitis Day
    • Making a Difference
      • Access to Sanofi Diabetes Medicines During COVID-19
    • Sanofi’s Transformational Science on Display at ASCO 2021
    • Sanofi US Earned Designation as a Great Place to Work-Certified™ Company in 2020
    • COVID-19 Highlights Value of Self-Care as First Line of Defense
    • Supporting Our Communities During the COVID-19 Pandemic
    • Message from Paul Hudson: We Stand Against Racism
    • Science & Solutions
    • Bonded by Family and Shared Hope for their Future
  • Patient Advocacy at Sanofi in the U.S.
• Science & Innovation
  • Clinical Trials
  • INVESTIGATOR SPONSORED STUDIES (ISS)
  • PARTNERING INITIATIVES
    • Sanofi iDEA Awards
  • Sanofi Innovation Awards
• Products & Resources
  • Prescription Products
  • Vaccines
    • Yellow Fever Vaccine Information
  • Colorado Disclosure
  • Vermont Disclosure
  • Generics
  • Patient Services
    • Aldurazyme® Support Program
    • ALPROLIX® [Coagulation Factor IX (Recombinant), FC Fusion Protein] Financial Assistance Programs
    • AUBAGIO® Support Program
    • Cablivi® Injection Support Program
    • CAPRELSA® Support Program
    • Cerdelga® Capsules Support Program
    • Cerezyme® Support Program
    • DUPIXENT® Injection Support Program
    • ELITEK® (rasburicase) IV Infusion Support Program
    • ELOCTATE® [Antihemophilic Factor (Recombinant), FC Fusion Protein] Financial Assistance Programs
    • Fabrazyme® Support Program
    • JEVTANA® (cabazitaxel) Support Program
    • KEVZARA® Injection Support Program
    • LEMTRADA® Support Program
    • LIBTAYO® Injection Support Program
    • Lumizyme® Support Program
    • Mozobil® (plerixafor injection) Support Program
    • Nexviazyme™ (avalglucosidase alfa-ngpt)
    • SARCLISA® (isatuxamab-irfc) Support Program
    • Thymoglobulin® (anti-thymocyte globulin (rabbit)) Support Program
    • Nexviazyme™ Support Programs
  • Resources for Healthcare Providers
• Our Responsibility
  • Access to Healthcare
  • Community Engagement
    • Community Involvement & Volunteerism
    • Employee Programs
    • Diabetes Camps
  • Diversity & Inclusion
    • Employee Resource Groups
    • Supplier Diversity
  • Healthy Planet
  • Pricing Principles
  • Responsible Business
    • Patient Safety
    • Ethical Responsibility
  • Contributions and Giving
    • Before You Apply
    • Charitable Donations
    • Sponsorships
    • TORCH Awards
• Careers
  • Benefits
  • Diversity
  • Postdoctoral Careers
  • Physician Careers
  • Students
  • Veterans
• Investors
• Media
• Sanofi Websites in the U.S.
• Legal notice
  • Sanofi California Privacy Notice
• Contact Us